DTC Telehealth Partnerships: Navigating Risks i...

By HEOR Staff Writer

July 18, 2025

The “DTC Investigation 2025” report by U.S. Senators Durbin, Sanders, Warren, and Welch highlights the emergence of DTC telehealth partnerships. These partnerships form between pharmaceutical companies, specifically Pfizer and Eli Lilly, and teleh...
NICE’s Ribociclib Breast Cancer Guidance: A New Era for High-Risk Patie...
Efficacy and Insights of Transdiagnostic Mental Health Apps for Depression an...
T1 Diabetes Care with an Implantable Glucose Device
Lenacapavir HIV Prevention: Gilead’s Strategic Agreement to Enhance Acc...
Revolutionizing Pediatric Care: Approval of Malaria Medicine for Newborns
How Gene-Editing Therapies Are Revolutionizing ASCVD Treatment and Market Tra...
EMA 2024 Report Highlights: Innovations in Medicine Approval and Regulatory A...
NICE Approves Transformative Multiple Myeloma Treatment
EHK Clusters 2026 Report: Enhancements in Dutch Risk Equalization for High-Co...
Pfizer Conference Insights: Analyzing Bourla’s Strategic Vision Amid Po...
Revitalizing Innovation: The Impact of UK Medicine Payment Rates
Blinatumomab Benefit Assessment for ALL and Health Economics